Lavipharm S.A. engages in the research, development, manufacturing, import, marketing, sale, and wholesaling of pharmaceutical, dermocosmetic, and healthcare products in Greece and internationally. The company offers pharmaceutical products for cardiology, chronic pain and oncology, central nervous system, general medicine, gastrointestinal system, and urology; and over the counter (OTC) drugs, such as antiseptics, anagelsics, and anti-lice treatment products. It also provides a range of skincare products. The company was founded in 1911 and is based in Paiania, Greece.
Stock data | 2024 | Change |
---|---|---|
Price | $0.9116022099447513 | N/A |
Market Cap | $153.03M | N/A |
Shares Outstanding | 167.87M | N/A |
Employees | 285.00 | N/A |